These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 1365450)

  • 61. Rapid release of antipsychotic drugs from dopamine D2 receptors: an explanation for low receptor occupancy and early clinical relapse upon withdrawal of clozapine or quetiapine.
    Seeman P; Tallerico T
    Am J Psychiatry; 1999 Jun; 156(6):876-84. PubMed ID: 10360126
    [TBL] [Abstract][Full Text] [Related]  

  • 62. N-fluoroalkylated and N-alkylated analogues of the dopaminergic D-2 receptor antagonist raclopride.
    Lannoye GS; Moerlein SM; Parkinson D; Welch MJ
    J Med Chem; 1990 Sep; 33(9):2430-7. PubMed ID: 2391685
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Normal database of dopaminergic neurotransmission system in human brain measured by positron emission tomography.
    Ito H; Takahashi H; Arakawa R; Takano H; Suhara T
    Neuroimage; 2008 Jan; 39(2):555-65. PubMed ID: 17962043
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Positron emission tomography imaging of amphetamine-induced dopamine release in the human cortex: a comparative evaluation of the high affinity dopamine D2/3 radiotracers [11C]FLB 457 and [11C]fallypride.
    Narendran R; Frankle WG; Mason NS; Rabiner EA; Gunn RN; Searle GE; Vora S; Litschge M; Kendro S; Cooper TB; Mathis CA; Laruelle M
    Synapse; 2009 Jun; 63(6):447-61. PubMed ID: 19217025
    [TBL] [Abstract][Full Text] [Related]  

  • 65. PET demonstrates different behaviour of striatal dopamine D-1 and D-2 receptors in early Parkinson's disease.
    Rinne JO; Laihinen A; Någren K; Bergman J; Solin O; Haaparanta M; Ruotsalainen U; Rinne UK
    J Neurosci Res; 1990 Dec; 27(4):494-9. PubMed ID: 1981915
    [TBL] [Abstract][Full Text] [Related]  

  • 66. 18F-desmethoxyfallypride: a fluorine-18 labeled radiotracer with properties similar to carbon-11 raclopride for PET imaging studies of dopamine D2 receptors.
    Mukherjee J; Yang ZY; Brown T; Roemer J; Cooper M
    Life Sci; 1996; 59(8):669-78. PubMed ID: 8761017
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Distribution of dopamine D1-D4 receptor subtypes in human dorsal vagal complex.
    Hyde TM; Knable MB; Murray AM
    Synapse; 1996 Nov; 24(3):224-32. PubMed ID: 8923662
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Positron emission tomography (PET) study: the effects of 6R-L-erythro-5,6,7,8-tetrahydrobiopterin (R-THBP, SUN 0588) on the central dopamine D1, D2 and D3 receptors in rhesus monkey.
    Tani Y; Ishihara T; Kanai T; Ohno T; Onoe H; Watanabe Y; Andersson J; Lilija A; Westerberg G; Hartvig P
    Adv Exp Med Biol; 1993; 338():327-30. PubMed ID: 8304130
    [No Abstract]   [Full Text] [Related]  

  • 69. In vitro and in vivo evaluation of [123I]IBZM: a potential CNS D-2 dopamine receptor imaging agent.
    Kung HF; Pan S; Kung MP; Billings J; Kasliwal R; Reilley J; Alavi A
    J Nucl Med; 1989 Jan; 30(1):88-92. PubMed ID: 2783457
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Decreases in dopamine receptors but not in dopamine transporters in alcoholics.
    Volkow ND; Wang GJ; Fowler JS; Logan J; Hitzemann R; Ding YS; Pappas N; Shea C; Piscani K
    Alcohol Clin Exp Res; 1996 Dec; 20(9):1594-8. PubMed ID: 8986209
    [TBL] [Abstract][Full Text] [Related]  

  • 71. PET analysis of human dopamine receptor subtypes using 11C-SCH 23390 and 11C-raclopride.
    Farde L; Halldin C; Stone-Elander S; Sedvall G
    Psychopharmacology (Berl); 1987; 92(3):278-84. PubMed ID: 2957716
    [TBL] [Abstract][Full Text] [Related]  

  • 72. In vivo effects of olanzapine on striatal dopamine D(2)/D(3) receptor binding in schizophrenic patients: an iodine-123 iodobenzamide single-photon emission tomography study.
    Dresel S; Mager T; Rossmüller B; Meisenzahl E; Hahn K; Möller HJ; Tatsch K
    Eur J Nucl Med; 1999 Aug; 26(8):862-8. PubMed ID: 10436199
    [TBL] [Abstract][Full Text] [Related]  

  • 73. In vivo SPECT imaging of CNS D-2 dopamine receptors: initial studies with iodine-123-IBZM in humans.
    Kung HF; Alavi A; Chang W; Kung MP; Keyes JW; Velchik MG; Billings J; Pan S; Noto R; Rausch
    J Nucl Med; 1990 May; 31(5):573-9. PubMed ID: 2140408
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Effects of endogenous dopamine on kinetics of [3H]N-methylspiperone and [3H]raclopride binding in the rat brain.
    Young LT; Wong DF; Goldman S; Minkin E; Chen C; Matsumura K; Scheffel U; Wagner HN
    Synapse; 1991 Nov; 9(3):188-94. PubMed ID: 1776131
    [TBL] [Abstract][Full Text] [Related]  

  • 75. In vivo studies of [125I]iodobenzamide and [11C]iodobenzamide: a ligand suitable for positron emission tomography and single photon emission tomography imaging of cerebral D2 dopamine receptors.
    Wong DF; Wilson AA; Chen C; Minkin E; Dannals RF; Ravert HT; Sanchez-Roa P; Villemagne V; Wagner HN
    Synapse; 1992 Nov; 12(3):236-41. PubMed ID: 1481143
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [11C]raclopride-PET studies of the Huntington's disease rate of progression: relevance of the trinucleotide repeat length.
    Antonini A; Leenders KL; Eidelberg D
    Ann Neurol; 1998 Feb; 43(2):253-5. PubMed ID: 9485067
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Multiple system atrophy: natural history, MRI morphology, and dopamine receptor imaging with 123IBZM-SPECT.
    Schulz JB; Klockgether T; Petersen D; Jauch M; Müller-Schauenburg W; Spieker S; Voigt K; Dichgans J
    J Neurol Neurosurg Psychiatry; 1994 Sep; 57(9):1047-56. PubMed ID: 8089667
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Simultaneous 99mTc and 123I dual-isotope brain striatal phantom single photon emission computed tomography: validation of 99mTc-TRODAT-1 and 123I-IBZM simultaneous dopamine system brain imaging.
    Kao PF; Wey SP; Yang AS
    Kaohsiung J Med Sci; 2009 Nov; 25(11):601-7. PubMed ID: 19858039
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Dose dependent occupancy of central dopamine D2 receptors by the novel neuroleptic CP-88,059-01: a study using positron emission tomography and 11C-raclopride.
    Bench CJ; Lammertsma AA; Dolan RJ; Grasby PM; Warrington SJ; Gunn K; Cuddigan M; Turton DJ; Osman S; Frackowiak RS
    Psychopharmacology (Berl); 1993; 112(2-3):308-14. PubMed ID: 7871035
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Comparison of intravenous and intraperitoneal [123I]IBZM injection for dopamine D2 receptor imaging in mice.
    Meyer PT; Salber D; Schiefer J; Cremer M; Schaefer WM; Kosinski CM; Langen KJ
    Nucl Med Biol; 2008 Jul; 35(5):543-8. PubMed ID: 18589298
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.